LivaNova PLC

Ownership Transactions Reported by 25 Insiders

Symbol
LIVN on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
20 Eastbourne Terrace, London, United Kingdom

Insiders trading volume in the past year

LivaNova PLC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Damien McDonald CEO, Director $14.3M Mar 30, 2023
Vladimir Makatsaria Chief Executive Officer, Director $8.4M Mar 30, 2025
Alex Shvartsburg Chief Financial Officer $3.59M Mar 30, 2025
Ahmet Tezel Chief Innovation Officer $2.4M Mar 30, 2025
Michael Damon Hutchinson Chief Legal Officer $2.32M Mar 30, 2025
Stephanie Bolton President, Global Epilepsy $2.15M Mar 30, 2025
Franco Poletti President, Cardiopulmonary $1.82M Mar 30, 2025
Daniel J. Moore Director $1.81M -$3.4M -65.3% Jun 3, 2024
Trui Hebbelinck Chief Human Resources Officer $1.71M Mar 30, 2024
Marco Dolci President CP $1.71M Mar 30, 2023
Natalia Kozmina Chief Human Resources Officer $1.5M Mar 30, 2025
Arthur L. Rosenthal Director $1.22M Jun 15, 2022
William A. Kozy Director $1.11M Mar 30, 2025
Keyna Pidcock Skeffington General Counsel $1M Sep 15, 2022
Sharon O'Kane Director $687K Jun 15, 2024
Alfred J. Novak Director $653K Jun 15, 2022
Seng Stacy Enxing Director $648K Jun 15, 2024
Francesco Bianchi Director $571K -$134K -19% Dec 11, 2024
Andrea Lynn Saia Director $559K Dec 31, 2023
Todd C. Schermerhorn Director $506K Jun 15, 2024
Peter M. Wilver Director $384K Jun 15, 2024
Brooke Story Director $370K Jun 15, 2024
Hugh M. Morrison Director $272K Jun 29, 2021
Susan M. Podlogar Director $129K Dec 15, 2024
James Christopher Barry Director $69.8K Dec 15, 2024

Recent Insider Transactions by Companies or Individuals for LivaNova PLC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.